To diagnose lung cancer and determine the optimal treatment strategy, physicians typically rely on tissue examination. However, taking biopsies is ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Robotic surgery was first introduced in the late 20th century and has long since found its place in the medical community.

In celebration of a decade of powerful advocacy and progress, Rison resident and lung cancer survivor, Melinda McKnight, will travel to Washington, D.C., for the American Lung Association’s 2025 LUNG ...

Ultrasensitive Liquid Biopsy Tech Spots Cancer Earlier Than ... 2024 — The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those ...

and small cell lung cancer (SCLC) are the two main types of lung cancer. The staging and progression of these two types are different. Once the type of lung cancer has been identified, healthcare ...

Targeted therapy in metastatic non–small cell lung cancer had a 62% survival advantage ... costs (available from the insurance database). All patients had lung cancer confirmed through biopsy. Data ...

Ryan Nguyen, DO, physician and researcher at the University of Illinois Chicago, emphasizes the transformative impact of immunotherapy in non–small cell lung cancer (NSCLC) and the need for ...

Prostate cancer is the most ... based on small or non-randomized studies. "We now have a big randomized trial showing that, yes, transperineal biopsy is better in certain respects—although ...

Small-cell lung cancer (SCLC) is the most aggressive type of lung cancer. Each year in the U.S., about 30,000 to 35,000 people are diagnosed with it. For most, it has already spread to distant ...

Leadoptik has entered a research partnership with Stanford Medicine, focusing on AI-enhanced real-time optical imaging usage in lung cancer biopsy. This collaboration is set to focus on assessing ...

An important aspect of this study was its use of liquid biopsy — a blood test that detects cancer ... a patient has received may also play a role in recurrence. Non-small-cell lung cancer (NSCLC) is ...